Comparación farmacocinética de Sinemetây Grifoparkinâ (levodopa/carbidopa 250/25 mg) en pacientes con enfermedad de Parkinson avanzada: un estudio con dosis única

por Chaná C,Pedro, Fierro H,Angélica, Reyes-Parada,Miguel, Sáez-Briones,Patricio
Publicado 2003

Protein intake and the use of levodopa in patients with Parkinson's disease

por de Moraes Fracasso,Bianca, Barcelos Morais,Maite, Gomez,Rosane, Hilbig,Arlete, Iraci Rabito,Estela
Publicado 2013

Effects of Carbidopa Premedication on ¹⁸F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis

por Marie Bros, Timothée Zaragori, Fabien Rech, Marie Blonski, Gabriela Hossu, Luc Taillandier, Pierre-Yves Marie, Antoine Verger
Publicado 2021

Parkinson’s disease managing reversible neurodegeneration

por Hinz M, Stein A, Cole T, McDougall B, Westaway M
Publicado 2016

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]

por Hinz M, Stein A, Cole T, McDougall B, Westaway M
Publicado 2020

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]

por Hinz M, Stein A, Cole T, McDougall B, Westaway M
Publicado 2020

Von Economo’s disease and postencephalitic parkinsonism responsive to carbidopa and levodopa

por Bigman DY, Bobrin BD
Publicado 2018

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients

por Constantin VA, Szász JA, Orbán-Kis K, Rosca EC, Popovici M, Cornea A, Bancu LA, Ciorba M, Mihály I, Nagy E, Szatmári S, Simu M
Publicado 2020

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients

por Szász JA, Constantin VA, Orbán-Kis K, Rácz A, Bancu LA, Georgescu D, Szederjesi J, Mihály I, Fárr AM, Kelemen K, Vajda T, Szatmári S
Publicado 2019

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden

por Modugno N, Antonini A, Tessitore A, Marano P, Pontieri FE, Tambasco N, Canesi M, Fabbrini G, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Gualberti G, Lopiano L
Publicado 2020

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease

por Hauser RA, Ellenbogen A, Khanna S, Gupta S, Modi NB
Publicado 2018